A prospective study of safety, efficacy and acceptability of postpartum insertion of intrauterine contraceptive device in a tertiary care hospital in Maharashtra, India

Gaikwad, Nandkishor B.; Poornima, M; Lipare, Atul

doi:10.18203/2320-1770.ijrcog20202753

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The major cause for removing the PPIUCD was excessive bleeding that was causing discomfort. In Nandkishor B et al [14] studies, The majority of patients in this study were between the ages of 21 and 26 (58.7%), with the least percentage being above 30 years old (3.3 percent). The majority of patients in this study were primigravida (44%) and the lowest number belonged to gravida 6 (6%).…”

Section: Discussionmentioning

confidence: 45%

Study the efficacy and compliance of postpartum intrauterine device

Parvathaneni¹,

Suneetha²

2022

Int. J. Clin. Obstet. Gynaecol.

View full text Add to dashboard Cite

Background: The postpartum phase is crucial in a woman's life since it necessitates the care of her newborn as well as the prevention of undesired pregnancies. This is the time of year when women are most likely to seek contraceptive counsel and have unmet contraception needs addressed. Postpartum IUCD is long-acting contraception that can be used right after a baby is born or within 48 hours. Aim: This study aims to look at the efficacy and patient compliance with the Postpartum Intrauterine Device. Materials and Methods:This study is a retrospective study conducted in a tertiary health care center from November 2018 to November 2019. Results: PPIUCD patients councilled were 2000. 500 patients were the number of patients who accepted service and participated in the study. The average age of those who accepted the facility was 21-25 years old, and 53.4 percent were second-time mothers who had their second kid sooner than expected. 86.6 percent of the patients were educated, demonstrating the importance of female education on contraception. Because of the surgical delivery, 59 percent of patients opted intracasarean PPIUCD to extend the next conception. The choice of this method was based on the fact that it did not require a second visit for contraception and had no hormonal side effects. Despite counseling 2000 patients, only 500 chose this strategy, owing to the fact that they were not accompanied by partners and were unable to make decisions. After 6 weeks of follow-up, 75 percent of patients had no complaints, whereas 96.4 percent of patients had no complaints after 6 months. There was not a single infection or perforation patient. Seven patients were expelled after six weeks, while two patients were expelled after six months. Only 14 patients requested PPIUCD removal. Conclusion: PPIUCD is a highly effective, nonhormonal, long-acting, and reversible contraceptive method. To increase the use of this method, extreme motivation and counselling from the couple's antenatal period are required.

show abstract

Section: Discussionmentioning

confidence: 45%